Eli Lilly has had a presence in Kinsale since 1978, a relationship that has seen both places prosper and grow across the ...

Eli Lilly poised for 30-50% growth in 12 months with a strong value and growth nexus. Click here to read more on LLY stock.

Eli Lilly and Company (NYSE:LLY) is one of the Jim Cramer Reveals Potential US Rare Earth Trump Card & Discusses These 11 ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

Eli Lilly and Company (NYSE:LLY) is one of Best Dividend Stocks to Buy for Dependable Dividend Growth. According to Adam ...

Lilly CEO Dave Ricks acknowledged in his company's first-quarter earnings call on May 3 that expanding tariffs "would have a negative effect on Lilly and for our industry." ...

Instead, Ricks said tax incentives and extending Trump’s 2017 tax cuts would help. “The announced tariffs currently in effect do not materially change Lilly’s 2025 financial outlook,” he said.

Novo Nordisk cut off Hims & Hers Health from selling lower-priced Wegovy on Monday morning, but its explanation for the ...

Eli Lilly & Co. has emerged as one ... CEO David Ricks and his team have shown remarkable conviction in targeting diabetes and obesity as key growth drivers, backing that vision with massive ...

Why Eli Lilly CEO David Ricks is one of Barron’s Top CEOs of 2025. ... Ricks Is the King of Pharma, Thanks to Lilly’s Zepbound. By Josh Nathan-Kazis. Share. Resize. Reprints. In this article.